Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug


Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.

Read more...


Tags: Health, Science, Pharmaceuticals, Gilead Sciences, Big Pharma, Gilead, Coronavirus, Covid 19, Sars Cov 2, Remdesivir, Pharma Giant Gilead

Source:  https://gizmodo.com/pharma-giant-gilead-retracts-request-fda-extend-monopol-1842500853




Related:
March 20, 2020 at 3:37 PM Hydroxychloroquine, chloroquine and other potential COVID-19 treatments explained
March 19, 2020 at 12:45 PM FDA testing coronavirus treatments including chloroquine, plasma from recovered COVID-19 patients
March 18, 2020 at 7:40 AM Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials
March 16, 2020 at 1:51 PM First human trial for coronavirus vaccine begins